Afghanistan vs Norway: Previously treated cases tested for RR-/MDR-TB
Afghanistan
100.0%
in 2024
Norway
100.0%
in 2024
Afghanistan rank
1st
Norway rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Afghanistan
- Norway
How they compare
Afghanistan currently reports 100.0% against 100.0% in Norway, a difference of 0.0%.
The two have swapped places 2 times across 13 shared years of data; in 2010 it was Norway ahead.
Afghanistan ranks 1st and Norway ranks 1st of 180 countries.
Norway has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Norway | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 40.7% | 62.2% | 21.5% | Norway |
| 2020s | 89.0% | 95.0% | 6.0% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Afghanistan or Norway?
- Afghanistan, at 100.0% against 100.0% in Norway as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Afghanistan and Norway?
- 0.0%, with Afghanistan ahead.
- How many years of comparable data are there for Afghanistan and Norway?
- 13 years are reported by both, from 2010 to 2024.
- How do Afghanistan and Norway rank globally for previously treated cases tested for rr-/mdr-tb?
- Afghanistan ranks 1st and Norway ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.